Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degeneration.

PURPOSE This study was conducted to investigate the correlation of genetic, sociodemographic, and behavioral risk factors with second eye progression to end-stage AMD. METHODS One hundred and eight patients with end-stage AMD in one or both eyes were included in a retrospective time-to-event analysis of the onset of end-stage AMD in the second eye. Multivariate Cox regression survival analysis was performed for sex, age, smoking, body mass index (BMI), education, and 16 single nucleotide polymorphisms (SNPs) associated with AMD. RESULTS Except for education, all sociodemographic and behavioral risk factors analyzed were significantly associated with a more rapid progression toward second eye involvement. Hazard ratios (HRs) were 2.6 (95% confidence interval [CI], 1.4-5.0) for female sex; 5.0 (95% CI, 2.0-12.5) for age >80; 2.2 (95% CI, 1.1-4.1) for BMI >30; and 4.4 (95% CI, 1.4-14.3) for >40 pack years, compared with the referent groups. Carriers of the lipoprotein lipase (LPL; rs12678919) risk alleles were at risk for more rapid progression to end-stage AMD in the second eye compared with the referent wild-type genotype (HR 2.0; 95% CI, 1.0-3.6). For complement factor I (CFI; rs10033900), homozygous carriers of the risk allele progressed faster than wild-type individuals (HR 2.2; 95% CI, 1.1-4.3). CONCLUSIONS Sociodemographic, behavioral, and genetic risk factors are associated with the rate of second eye progression toward end-stage AMD. The findings of this study underline the importance of lifestyle factors and the complement pathway in AMD progression and suggest a role of the high-density-lipoprotein metabolism in second eye progression.

[1]  Richard Wormald,et al.  Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. , 2012, Ophthalmology.

[2]  J. Ordovás,et al.  Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. , 2011, American journal of ophthalmology.

[3]  L. Fan,et al.  Toll‐like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[5]  Glenn J Jaffe,et al.  Reticular drusen associated with geographic atrophy in age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[6]  Bernd Kirchhof,et al.  Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[7]  H. Chin,et al.  LOC387715/HTRA1 polymorphisms, smoking and combined effects on exudative age‐related macular degeneration in a Korean population , 2010, Clinical & experimental ophthalmology.

[8]  M. Brantley,et al.  The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration , 2010, British Journal of Ophthalmology.

[9]  Margaret A. Pericak-Vance,et al.  Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.

[10]  Aaron Y. Lee,et al.  Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.

[11]  H. Meng,et al.  SELF‐REPORTED VERSUS MEASURED HEIGHT AND WEIGHT IN THE HEALTH AND RETIREMENT STUDY , 2010, Journal of the American Geriatrics Society.

[12]  Dean Y. Li,et al.  Genetic and Functional Dissection of HTRA1 and LOC387715 in Age-Related Macular Degeneration , 2010, PLoS genetics.

[13]  Sharon D. Solomon,et al.  RISK FACTORS FOR SECOND EYE PROGRESSION TO ADVANCED AGE-RELATED MACULAR DEGENERATION: SST Report No. 21 Submacular Surgery Trials Research Group , 2009, Retina.

[14]  T. Meitinger,et al.  Age‐related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene , 2009, Human mutation.

[15]  B. Fridley,et al.  Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[16]  M. Daly,et al.  Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.

[17]  B. J. Klevering,et al.  The spectrum of phenotypes caused by variants in the CFH gene. , 2009, Molecular immunology.

[18]  C. Klaver,et al.  Complement component C3 and risk of age-related macular degeneration. , 2009, Ophthalmology.

[19]  S. Ennis,et al.  Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study , 2008, The Lancet.

[20]  J. Ott,et al.  Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss , 2008, Journal of Medical Genetics.

[21]  G. Parmigiani,et al.  Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.

[22]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[23]  M. Tremblay,et al.  Estimates of obesity based on self-report versus direct measures. , 2008, Health reports.

[24]  Johanna M Seddon,et al.  Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.

[25]  Sharon D. Solomon,et al.  Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group. , 2007, A M A Archives of Ophthalmology.

[26]  P. Bora,et al.  The role of complement system in ocular diseases including uveitis and macular degeneration. , 2007, Molecular immunology.

[27]  J. Haines,et al.  Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. , 2007, Human molecular genetics.

[28]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[29]  G. Abecasis,et al.  Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. , 2007, Human molecular genetics.

[30]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[31]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration , 2006 .

[32]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[33]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[34]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[35]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[36]  F. Holz,et al.  Y402H-Polymorphismus im Komplementfaktor H und altersabhängige Makuladegeneration (AMD) , 2005, Der Ophthalmologe.

[37]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[38]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[39]  Robyn H Guymer,et al.  The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. , 2004, Investigative ophthalmology & visual science.

[40]  Johanna M Seddon,et al.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.

[41]  A. Ho,et al.  RISK FACTORS FOR CHOROIDAL NEOVASCULARIZATION AND VISION LOSS IN THE FELLOW EYE STUDY OF CNVPT , 2003, Retina.

[42]  Johanna M Seddon,et al.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.

[43]  T. Weaver,et al.  Miniaturized sealed‐tube allele‐specific PCR , 2002, Human mutation.

[44]  S. Nitzke,et al.  Self-reported versus measured weight and height in an older adult meal program population. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[45]  C. Duijn,et al.  Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.

[46]  I. Shami Smoking and age-related maculopathy , 1997 .

[47]  A. Hofman,et al.  Age-related macular degeneration and smoking. The Rotterdam Study. , 1996 .

[48]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[49]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[50]  S. Ennis,et al.  Support for the involvement of complement factor I in age-related macular degeneration , 2010, European Journal of Human Genetics.

[51]  M. Daly,et al.  Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.

[52]  R. Kuczmarski,et al.  Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, Journal of the American Dietetic Association.

[53]  Judith Alexander,et al.  Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. , 1997, Archives of ophthalmology.

[54]  P. Mitchell,et al.  Smoking and age-related maculopathy. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.

[55]  R. Klein,et al.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.